Managed Markets Network^®

Login

Precision Medicine in Oncology

News

Quality of Life Improvement With Docetaxel Plus Plinabulin Versus Pegfilgrastim

Quality of Life Improvement With Docetaxel Plus Plinabulin Versus Pegfilgrastim

January 17, 2020

clonoSEQ Assay Medicare Coverage Expanded to Include MRD in CLL

January 13, 2020 – Maggie L. Shaw

Blueprint Medicines' Ayvakit Approved for Rare GIST With PDGFRA Mutation

January 10, 2020 – Maggie L. Shaw

Partnership Seeks to Offer Combined Somatic, Germline Testing to Guide Cancer Treatment

January 06, 2020 – Mary Caffrey

Journals

The Democratization of Precision Medicine: A Clinician's Perspective on the Future of Oncology Care - Q&A With Neil Vasan, MD, PhD

January 07, 2020

Laboratory Logistics: An Operational Perspective on Precision Medicine - Q&A With Claudia French

January 07, 2020

The Importance of the Clinician-Pathologist Relationship in Precision Oncology - Q&A With Ryan K. Olson, MD

January 07, 2020

Conferences

The Fast Pace of CAR T-Cell Innovation Caused an Array of Challenges in Treatment

November 09, 2019 – Laura Joszt

More From TAILORx: Adding Clinical Risk to Genomic Testing Can Guide Therapy Choices in Breast Cancer

June 03, 2019 – Mary Caffrey

Maintenance Olaparib Aids PFS in BRCA-Mutated Metastatic Pancreatic Cancer, but Not OS

June 02, 2019 – Allison Inserro

Multimedia

Dr C. Ola Landgren: MRD Is a Growing Topic of Interest in Cancer

Dr Lindsey Roeker on Using MRD for Decision Making

ACCOUNTABLE CARE DELIVERY CONGRESS

CONTINUING EDUCATION

Interactive Tools

Managed Care Podcast

Panel Discussions

Information for Reviewers

Information for Authors

Formulary Central

Clinical Study Summaries

Study Summaries

Terms & Conditions

Like Us On Facebook

Follow Us On Twitter

Check us out on LinkedIn

Follow us on Instagram

Subscribe us on YouTube

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.